Nishan Garabedian Christopher Insider Profile
4 Followers
Nishan Garabedian Christopher, President & CEO, Director at Sarepta Therapeutics, holds 29.55K shares in Sarepta Therapeutics (Ticker: SRPT).
Nishan Garabedian Christopher's Trading History
| SRPTSarepta Therapeutics | Mar 03, 2015 | President & CEO, Director | Uninformative Buy | 9.45K | $447.12K | |
SRPT Insider Shares: 29.55K (0.07%) | ||||||
You May Also Like
Nishan Garabedian Christopher insider profile FAQ
What is the percentage of profitable transactions made by Nishan Garabedian Christopher?
The percentage of profitable transactions made by Nishan Garabedian Christopher is 50%.
What is the average return per transaction made by Nishan Garabedian Christopher?
The average return per transaction made by Nishan Garabedian Christopher is 307.80%.
What stocks does Nishan Garabedian Christopher hold?
Nishan Garabedian Christopher holds: SRPT stocks.
What was Nishan Garabedian Christopher’s latest transaction?
Nishan Garabedian Christopher’s latest transaction was an Uninformative Buy of $9.45K.
What was Nishan Garabedian Christopher's most profitable transaction?
Nishan Garabedian Christopher’s most profitable transaction was an Informative Buy of SRPT stock on December 16, 2011. The return on the trade was 651.70%.
What is Nishan Garabedian Christopher's role in Sarepta Therapeutics?
Nishan Garabedian Christopher's role in Sarepta Therapeutics is President & CEO, Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.
TipRanks measures corporate insiders by the stock transactions they report to the SEC. See how TipRanks ranks experts and calculates performance.
